a2 Milk lifts profit outlook despite China formula sales drop
Supply issues largely resolved, full-year earnings to beat 2025
7 July 2026
1 minute read
By: New Zealand's a2 Milk on Tuesday said that certain factors contributing to the availability of its key Chinese-label infant milk formula (IMF) product are substantially resolved, but have contributed to an around 14% decline in annual sales for the product, reported Reuters.
However, the dairy producer added it now expects net profit after tax for fiscal 2026 to be slightly higher than last year's NZ$202.9 million ($115.63 million), compared with its earlier outlook of similar or lower earnings.
($1 = 1.7547 New Zealand dollars)
